3,4-diarylpyrazoline derivative

ID: ALA196989

Chembl Id: CHEMBL196989

PubChem CID: 22267384

Max Phase: Preclinical

Molecular Formula: C21H24ClN5O2S

Molecular Weight: 445.98

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  C/N=C(\NS(=O)(=O)N1CCCC1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1

Standard InChI:  InChI=1S/C21H24ClN5O2S/c1-23-21(25-30(28,29)26-13-5-6-14-26)27-15-19(16-7-3-2-4-8-16)20(24-27)17-9-11-18(22)12-10-17/h2-4,7-12,19H,5-6,13-15H2,1H3,(H,23,25)

Standard InChI Key:  VFBQYYRPOZMAQL-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA196989

   5-(4-chlorophenyl)-N'-methyl-4-phenyl-N-pyrrolidin-1-ylsulfonyl-3,4-dihydropyrazole-2-carboximidamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 445.98

Molecular Weight (Monoisotopic): 445.1339

AlogP: 3.06

#Rotatable Bonds: 4

Polar Surface Area: 77.37

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.54

CX Basic pKa: 4.68

CX LogP: 3.18

CX LogD: 3.18

Aromatic Rings: 2

Heavy Atoms: 30

QED Weighted: 0.58

Np Likeness Score: -0.99

References

1. Lange JH, van Stuivenberg HH, Veerman W, Wals HC, Stork B, Coolen HK, McCreary AC, Adolfs TJ, Kruse CG..  (2005)  Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicity.,  15  (21): [PMID:16140010] [10.1016/j.bmcl.2005.07.054]

2. Wittgen HG, van den Heuvel JJ, van den Broek PH, Dinter-Heidorn H, Koenderink JB, Russel FG..  (2011)  Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4.,  39  (7): [PMID:21511945] [10.1124/dmd.110.037812]

Source

Source(1):

• Scientific Literature